HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,368,893 | +14.2% | 29,120 | +1.6% | 0.05% | +17.9% |
| Q2 2023 | $2,948,812 | -6.0% | 28,671 | -0.3% | 0.04% | -15.2% |
| Q1 2023 | $3,138,539 | -3.5% | 28,757 | +0.6% | 0.05% | -13.2% |
| Q4 2022 | $3,253,087 | +110.3% | 28,586 | +14.4% | 0.05% | +76.7% |
| Q3 2022 | $1,547,000 | -21.9% | 24,998 | +0.6% | 0.03% | -25.0% |
| Q2 2022 | $1,981,000 | +180.6% | 24,838 | +269.9% | 0.04% | +233.3% |
| Q1 2022 | $706,000 | +0.1% | 6,714 | +2.7% | 0.01% | +9.1% |
| Q4 2021 | $705,000 | -2.2% | 6,539 | -0.6% | 0.01% | -21.4% |
| Q3 2021 | $721,000 | +4.2% | 6,579 | -11.0% | 0.01% | +7.7% |
| Q2 2021 | $692,000 | -60.4% | 7,388 | -61.1% | 0.01% | -64.9% |
| Q1 2021 | $1,746,000 | +27.4% | 18,973 | +1.3% | 0.04% | +23.3% |
| Q4 2020 | $1,371,000 | -7.2% | 18,736 | -1.5% | 0.03% | -16.7% |
| Q3 2020 | $1,477,000 | +50.6% | 19,012 | +7.7% | 0.04% | +44.0% |
| Q2 2020 | $981,000 | – | 17,659 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |